Search Results - "Settelmeier, Stephan"

Early timepoint ^99mTc-DPD whole body scintigraphy and quantitative SPECT/CT imaging for diagnosis of cardiac ATTR amyloidosis.

Authors: Settelmeier, Stephan Kessler, Lukas Hammersen, Noah et al.

Source: EJNMMI Research. 6/12/2026, Vol. 16 Issue 1, p1-11. 11p.

Anthracycline Therapy Modifies Immune Checkpoint Signaling in the Heart.

Authors: Korste, Sebastian Settelmeier, Stephan Michel, Lars et al.

Source: International Journal of Molecular Sciences. Apr2023, Vol. 24 Issue 7, p6052. 14p.

Demonstration of the Early Cardiac Bioavailability of a Non-Specific Cell-Targeted Peptide Using Radionuclide-Based Imaging In Vivo.

Authors: Settelmeier, Stephan Varasteh, Zohreh Staniszewska, Magdalena et al.

Source: Pharmaceuticals (14248247). Jun2023, Vol. 16 Issue 6, p824. 17p.

How Rapidly Does the FAPI PET Signal Reverse Following Therapy? Assessing the FAPI PET Signal in Hypertensive Cardiac Injury and Fibrosis in Mice.

Authors: Hosseini, Atefeh Haj-Yehia, Elias Korste, Sebastian et al.

Source: Journal of Nuclear Medicine. Nov2025, Vol. 66 Issue 11, p1757-1763. 7p.

Shining Damaged Hearts: Immunotherapy-Related Cardiotoxicity in the Spotlight of Nuclear Cardiology.

Authors: Kersting, David Settelmeier, Stephan Mavroeidi, Ilektra-Antonia et al.

Source: International Journal of Molecular Sciences. Apr2022, Vol. 23 Issue 7, p3802-N.PAG. 23p.

Prolyl hydroxylase domain 2 reduction enhances skeletal muscle tissue regeneration after soft tissue trauma in mice.

Authors: Settelmeier, Stephan Schreiber, Timm Mäki, Joni et al.

Source: PLoS ONE. 5/15/2020, Vol. 15 Issue 5, p1-21. 21p.

Troponins and brain natriuretic peptides for the prediction of cardiotoxicity in cancer patients: a meta-analysis.

Authors: Michel, Lars Mincu, Raluca I. Mahabadi, Amir A. et al.

Source: European Journal of Heart Failure. Feb2020, Vol. 22 Issue 2, p350-361. 12p. 5 Diagrams, 1 Chart.